Table 3.

Service factors in patients with pancreatic exocrine insufficiency, and results of adjusted univariable analysis of their association with initiation of PERT and clinical response

Service factorPatients with PEIAssociation with initiation of PERT, OR (95% CI)aAssociation with clinical response to PERT, OR (95% CI)a
FE1 result, n=182, mean (SD)92.9 (93.2)1.00 (0.99–1.00)1.00 (0.99–1.01)
FE1 repeated, n=182, n (%)42 (23.1)3.06 (1.38–6.77)b0.50 (0.14–1.75)
Pancreatic imaging performed, n=182, n (%)149 (81.9)2.53 (1.14–5.60)b0.44 (0.05–4.13)
Abnormal pancreatic imaging, n=143, n (%)67 (46.9)2.50 (1.20–5.25)b10.70 (1.62–70.70)b
Nutritional blood tests performed, n=182, n (%)124 (68.1)1.71 (0.90–3.25)2.50 (0.73–8.60)
Abnormal nutrition blood tests, n=124, n (%)65 (52.4)2.08 (1.07–4.04)b3.62 (0.87–15.10)
PERT prescribed, n=182, n (%)103 (56.6)n/an/a
Starting dose of PERT, median (IQR), IU/meal50,000 (0)n/a1.01 (0.98–1.05)
Dietitian referral, n=182, n (%)77 (42.3)n/a0.92 (0.22–3.86)
Followed up, n=182, n (%)99 (54.4)n/a0.70 (0.08–6.40)
Clinical response to PERT, n=81, n (%)67 (82.7)n/an/a
  • Reference categories for alcohol excess and smoking are ‘never’.

  • a = adjusted for age, sex and ethnicity;

  • b = p<0.05; CI = confidence interval; FE1 = faecal elastase-1; GI = gastrointestinal; IQR = interquartile range; n/a = not applicable; OR = odds ratio; PEI = pancreatic exocrine insufficiency; PERT = pancreatic enzyme replacement therapy; SD = standard deviation.